DK1100922T3 - Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine - Google Patents
Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccineInfo
- Publication number
- DK1100922T3 DK1100922T3 DK99938897T DK99938897T DK1100922T3 DK 1100922 T3 DK1100922 T3 DK 1100922T3 DK 99938897 T DK99938897 T DK 99938897T DK 99938897 T DK99938897 T DK 99938897T DK 1100922 T3 DK1100922 T3 DK 1100922T3
- Authority
- DK
- Denmark
- Prior art keywords
- ospc
- borrelia burgdorferi
- borreliacid
- epitopes
- vaccine
- Prior art date
Links
- 108700023315 OspC Proteins 0.000 title abstract 3
- 241000589969 Borreliella burgdorferi Species 0.000 title abstract 2
- 101710203379 Outer membrane porin C Proteins 0.000 title 1
- 101710160101 Outer membrane protein C Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 3
- 208000016604 Lyme disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001449 borreliacidal effect Effects 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9495598P | 1998-07-31 | 1998-07-31 | |
PCT/US1999/017270 WO2000006745A1 (en) | 1998-07-31 | 1999-07-30 | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1100922T3 true DK1100922T3 (da) | 2008-06-16 |
Family
ID=22248146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99938897T DK1100922T3 (da) | 1998-07-31 | 1999-07-30 | Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine |
Country Status (13)
Country | Link |
---|---|
US (2) | US6210676B1 (es) |
EP (1) | EP1100922B1 (es) |
JP (1) | JP3631960B2 (es) |
AT (1) | ATE386805T1 (es) |
AU (1) | AU5328299A (es) |
CA (1) | CA2332570C (es) |
CY (1) | CY1107944T1 (es) |
DE (1) | DE69938183T2 (es) |
DK (1) | DK1100922T3 (es) |
ES (1) | ES2302385T3 (es) |
NO (1) | NO329227B1 (es) |
PT (1) | PT1100922E (es) |
WO (1) | WO2000006745A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
ES2272296T3 (es) | 1999-06-18 | 2007-05-01 | Research Foundation Of State University Of New York | Grupos de borrelia burgdorferi que producen la enfermedad de lyme en humanos. |
EP1939294A1 (en) * | 2000-08-18 | 2008-07-02 | Research Foundation Of State University Of New York | Recombinant constructs of borrelia burgdorferi |
EP1311682B1 (en) * | 2000-08-18 | 2007-12-12 | Research Foundation Of State University Of New York | Recombinant constructs of borrelia burgdorferi |
EP1311540B1 (en) * | 2000-08-18 | 2007-12-19 | Research Foundation Of State University Of New York | Altered ospa of borrelia burgdorferi |
EP1865062A3 (en) * | 2000-08-18 | 2008-01-09 | Research Foundation Of State University Of New York | Altered OspA of Borrelia burgdorferi |
US20020142355A1 (en) * | 2000-11-14 | 2002-10-03 | Baylor College Of Medicine | Methods for the in vivo biotin labeling of polypeptides |
BRPI0719360B1 (pt) * | 2006-11-03 | 2016-09-06 | Intervet Int Bv | vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia |
EP2361930A3 (en) | 2007-03-26 | 2011-10-26 | Dako Denmark A/S | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
EP3023436A1 (en) | 2007-07-03 | 2016-05-25 | Dako Denmark A/S | Improved methods for generation, labeling and use of mhc multimers |
WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
WO2009135118A2 (en) * | 2008-05-02 | 2009-11-05 | Virginia Commonwealth University | Lyme disease vaccine |
US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
CN103229055A (zh) | 2010-09-27 | 2013-07-31 | 康奈尔大学 | 莱姆病的诊断方法 |
EP3029073B1 (en) * | 2010-10-20 | 2019-09-04 | Virginia Commonwealth University | Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
US9562079B2 (en) | 2012-04-18 | 2017-02-07 | Zoetis Services Llc | Vaccines and methods to treat lyme disease in dogs |
UY34745A (es) | 2012-04-18 | 2013-11-29 | Zoetis Llc | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
US11061028B2 (en) | 2014-09-24 | 2021-07-13 | Defined Diagnostics, Llc | Compositions and methods for the diagnosis of lyme disease |
CA3082959A1 (en) | 2017-12-04 | 2019-06-13 | Intervet International B.V. | Canine lyme disease vaccine |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5777095A (en) | 1988-10-24 | 1998-07-07 | Symbicom Aktiebolag | Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 |
US5385826A (en) | 1989-04-21 | 1995-01-31 | Gundersen Medical Foundation, Ltd. | Diagnostic assay for lyme disease |
DE4015911A1 (de) | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
JPH05506987A (ja) | 1990-03-07 | 1993-10-14 | エフ.ホフマン ― ラ ロシュ アーゲー | ライム病の診断方法 |
SG47447A1 (en) | 1990-06-15 | 1998-04-17 | Univ Yale | Compositions and methods for the prevention and diagnosis of lyme disease |
DE69408135T2 (de) * | 1993-04-29 | 1998-06-10 | Immuno Ag | Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene |
US5656451A (en) | 1993-07-30 | 1997-08-12 | Yale University | OspE, OspF, and S1 polypeptides in borrelia burgdorferi |
AU8091694A (en) * | 1993-10-26 | 1995-05-22 | United Biomedical Inc. | Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
US5558993A (en) | 1994-06-17 | 1996-09-24 | The Regents Of The University Of California | Cloned Borrelia burgdorferi virulence protein |
US5853987A (en) | 1995-04-24 | 1998-12-29 | The Texas A & M University System | Decorin binding protein compositions and methods of use |
EP1019546B1 (en) | 1996-03-26 | 2004-12-15 | Cylex, Inc. | Methods for measurement of lymphocyte function |
CA2253374C (en) * | 1996-05-02 | 2004-07-20 | Marianne Jartved Mathiesen | Novel osp-c derived peptide fragments |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
-
1999
- 1999-07-30 ES ES99938897T patent/ES2302385T3/es not_active Expired - Lifetime
- 1999-07-30 JP JP2000562527A patent/JP3631960B2/ja not_active Expired - Fee Related
- 1999-07-30 DK DK99938897T patent/DK1100922T3/da active
- 1999-07-30 US US09/364,083 patent/US6210676B1/en not_active Expired - Lifetime
- 1999-07-30 DE DE69938183T patent/DE69938183T2/de not_active Expired - Lifetime
- 1999-07-30 EP EP99938897A patent/EP1100922B1/en not_active Expired - Lifetime
- 1999-07-30 WO PCT/US1999/017270 patent/WO2000006745A1/en active IP Right Grant
- 1999-07-30 AU AU53282/99A patent/AU5328299A/en not_active Abandoned
- 1999-07-30 PT PT99938897T patent/PT1100922E/pt unknown
- 1999-07-30 AT AT99938897T patent/ATE386805T1/de active
- 1999-07-30 CA CA002332570A patent/CA2332570C/en not_active Expired - Lifetime
-
2000
- 2000-08-30 US US09/651,419 patent/US6464985B1/en not_active Expired - Lifetime
-
2001
- 2001-01-24 NO NO20010412A patent/NO329227B1/no not_active IP Right Cessation
-
2008
- 2008-05-13 CY CY20081100502T patent/CY1107944T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000006745A1 (en) | 2000-02-10 |
NO329227B1 (no) | 2010-09-20 |
PT1100922E (pt) | 2008-05-30 |
US6210676B1 (en) | 2001-04-03 |
EP1100922B1 (en) | 2008-02-20 |
CA2332570C (en) | 2009-12-08 |
US6464985B1 (en) | 2002-10-15 |
CA2332570A1 (en) | 2000-02-10 |
ES2302385T3 (es) | 2008-07-01 |
CY1107944T1 (el) | 2013-09-04 |
JP3631960B2 (ja) | 2005-03-23 |
DE69938183T2 (de) | 2009-02-19 |
AU5328299A (en) | 2000-02-21 |
EP1100922A1 (en) | 2001-05-23 |
ATE386805T1 (de) | 2008-03-15 |
NO20010412D0 (no) | 2001-01-24 |
DE69938183D1 (de) | 2008-04-03 |
NO20010412L (no) | 2001-03-29 |
JP2002523019A (ja) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1100922T3 (da) | Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine | |
Bonavia et al. | Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
WO2003078600A3 (en) | Human monoclonal antibodies to influenza m2 protein and methods of making and using same | |
NO995458L (no) | Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder | |
NO2010021I2 (no) | Denosumab | |
CY1108545T1 (el) | Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι | |
DE69609188D1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
BRPI0513135A (pt) | bibliotecas de polinucleotìdeos, método de produção das mesmas, método de identificação de um polinucleotìdeo, região de ligação, meio adequado para uso em um, dispositivo eletrÈnico e dispositivo | |
WO2007133623A3 (en) | Peptide diagnostic agent for lyme disease | |
FR2794865B1 (fr) | Methode de detection precoce des flavivirus et ses applications | |
EP1881064A2 (en) | HCV-Anti-core monoclonal antibodies | |
DK0528932T3 (da) | Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis | |
WO2005016132A3 (en) | Diagnostics for sars virus | |
DE60144201D1 (de) | Lawsonia intracellularis Impfstoff | |
DE69422634D1 (de) | Adeno-assozierter virus - dessen diagnostischen anwendung für frühe abtreibung | |
ATE353337T1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet | |
WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
Sun et al. | Immunodiagnosis of human dirofilariasis by enzyme-linked immunosorbent assay using recombinant DNA-derived fusion protein | |
King | Monoclonal antibody studies on rabies-related viruses | |
Crottet et al. | Covalent homodimers of murine secretory component induced by epitope substitution unravel the capacity of the polymeric Ig receptor to dimerize noncovalently in the absence of IgA ligand | |
FR2765688B1 (fr) | Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications | |
WO2001065262A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
BR9911609A (pt) | Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos | |
ATE340804T1 (de) | Hyphenspezifische faktoren aus candida albicans |